Icahn buys small stake in drugmaker Allergan: sources
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Tech selloff weighs down Wall Street as bond yields climb
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Francisco Partners to acquire Weave Communications for $650M
Allergen (AGN) PT Raised to $176 at Mizuho Securities
June 8, 2018 1:30 PM EDTMizuho Securities raised its price target on Allergen (NYSE: AGN) to $176.00 (from $150.00) while maintaining a Neutral rating.
Analyst Irina Koffler cited stronger Botox expectations in both migraine and cosmetic indications, and view recent investor activism as positive to AGN.
... More